News
Research Team Develops NIR Theranostic Dyes with OmiChem Reagent Support
Jan 29, 2026
Hefei, January 26, 2026 — A collaborative research team from Anhui Normal University and Anhui Polytechnic University has published a breakthrough study in the prestigious international journal Organic Letters. The work presents a palladium(II)-catalyzed dehydrogenative coupling strategy enabling the efficient and highly regioselective synthesis of β,β-directly linked BODIPY dimers and trimers.
The newly developed dyes exhibit strong intramolecular J-type excitonic coupling, resulting in tunable absorption and emission across the visible to near-infrared (500–800 nm) range, high fluorescence quantum yields, and excellent reactive oxygen species (ROS) generation capabilities. These properties make them highly promising candidates for integrated applications in near-infrared bioimaging and photodynamic therapy—collectively known as “theranostics.”
Notably, the success of this research was supported by high-quality chemical reagents. In the Acknowledgments section of the paper, the authors explicitly stated: “We thank Beijing Omiget Pharmaceutical Technology Co., Ltd. for providing key reagents used in this study.”
The article is now available online with the DOI: 10.1021/acs.orglett.5c05112.
This work not only opens a new pathway toward heavy-atom-free near-infrared triplet photosensitizers but also highlights the vital role of industry–academia collaboration in advancing cutting-edge scientific research. Beijing Omiget Pharmaceutical Technology Co., Ltd., as a specialized supplier of research reagents, continues to provide reliable support for innovation in the scientific community.
Organic Letters Article ASAP
DOI: 10.1021/acs.orglett.5c05112
The newly developed dyes exhibit strong intramolecular J-type excitonic coupling, resulting in tunable absorption and emission across the visible to near-infrared (500–800 nm) range, high fluorescence quantum yields, and excellent reactive oxygen species (ROS) generation capabilities. These properties make them highly promising candidates for integrated applications in near-infrared bioimaging and photodynamic therapy—collectively known as “theranostics.”
Notably, the success of this research was supported by high-quality chemical reagents. In the Acknowledgments section of the paper, the authors explicitly stated: “We thank Beijing Omiget Pharmaceutical Technology Co., Ltd. for providing key reagents used in this study.”
The article is now available online with the DOI: 10.1021/acs.orglett.5c05112.
This work not only opens a new pathway toward heavy-atom-free near-infrared triplet photosensitizers but also highlights the vital role of industry–academia collaboration in advancing cutting-edge scientific research. Beijing Omiget Pharmaceutical Technology Co., Ltd., as a specialized supplier of research reagents, continues to provide reliable support for innovation in the scientific community.
A Palladium(II)-Catalyzed Dehydrogenative Strategy to NIR-Emissive BODIPY Dimers and Trimers with Reactive Oxygen Species Generation Characteristics
Chunyan Pan, Zhengxin Kang, Fan Lv, Xiankang Zhang, Lei Zhang, Long Wang, Jiangang Gao, Erhong Hao, and Lijuan JiaoOrganic Letters Article ASAP
DOI: 10.1021/acs.orglett.5c05112
Share:






